LexDanaLexDanabeta
Inventor

TADASHI SHIMAMURA

Inventor
JP

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry8%
PatentTitleYear
12,458,640Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors202512,215,109Crystal of pyrazolo[3,4-d]pyrimidine202512,037,345Heterobicyclic compounds for inhibiting the activity of SHP2202411,236,096Fused pyrimidine compound or salt thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to TAIHO PHARMACEUTICAL CO LTD (4)· patent assignee history
2022–2025Based in JP· patent location history
2024–2025Patents assigned to OTSUKA PHARMA CO LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TAIHO PHARMACEUTICAL CO LTD42022–2025
OTSUKA PHARMA CO LTD22024–2025
Locations
LocationPatentsSpan
JP42022–2025